- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02694939
STAND Community Trial (STAND)
February 2, 2021 updated by: Florida International University
Effectiveness of MI Enhanced Behavior Therapy for Adolescents With ADHD
The proposed study evaluates the effectiveness of a family-based psychosocial treatment program for teens with ADHD (Supporting Teens' Academic Needs Daily; STAND) developed to be delivered in community settings.
STAND is BT enhanced by Motivational Interviewing (MI) that was developed (R34 MH092466) for teens with ADHD through a stakeholder informed process.
STAND consists of ten 50-minute sessions delivered by therapists with community-typical levels of training and supervision.
Across randomized controlled pilot (N=28; N=36) and efficacy trials (N=128), STAND demonstrates medium to large effects on ADHD and ODD symptoms and indices of academic and family impairment.
In the proposed study, 300 adolescents with ADHD who present for treatment at one of four community mental health agencies in Miami-Dade County, FL will be randomly assigned to STAND or agency usual care (UC).
Participating agency therapists also will be randomly assigned to deliver STAND or UC.
STAND therapists will receive a comprehensive treatment manual, three-day training, and weekly supervision from a project psychologist.
Participants will be screened by research staff in the community setting and enrolled on a rolling basis over 30 months.
Participants will be assessed at baseline, post-treatment, and three-month follow-up.
In line with RDoC, multi-method measures will be obtained for treatment outcome (family and academic impairment), treatment mediators (executive functioning, parent academic involvement, parent-teen communication, parent/adolescent motivation, ADHD symptoms), and moderators of effectiveness (patient, practitioner, service delivery, and organization characteristics).
Additional consumer perspective (satisfaction, therapeutic alliance) and agency fit (therapist competence, treatment fidelity, need for additional treatment, attendance, therapist attitude toward treatment, cost effectiveness) measures will also be obtained to evaluate effectiveness.
We will recruit an ethnically diverse sample (65% Hispanic, 19% African-American, 16% Non-Hispanic White) that is historically underrepresented in research, but ideal for evaluating therapy effectiveness.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
278
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Florida
-
Miami, Florida, United States, 33199
- Florida International University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
11 years to 17 years (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- ADHD diagnosis
- IQ of at least 70
- Enrollment in sixth through twelfth grade
Exclusion Criteria:
- history of autism spectrum disorder
- not attending a Miami-Dade County Public School
- a primary presenting problem other than ADHD, requiring immediate treatment of a different domain
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Single Group Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: STAND
Receives STAND intervention delivered in community mental health setting.
|
Parent-teen collaborative skills based behavior therapy targeting Executive functioning and Delay Aversion in Teens
|
Active Comparator: Usual Care
Receives usual care from community therapists.
|
Community Therapists free to deliver any therapy they feel is indicated.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
School Grades
Time Frame: 7 months
|
GPA
|
7 months
|
ADHD Symptoms
Time Frame: 7 months
|
Conners, ADHD Checklist
|
7 months
|
Behavior Problems in School
Time Frame: 7 months
|
Official Disciplinary Records from School District
|
7 months
|
Academic Problems
Time Frame: 7 months
|
Adolescent Academic Problems Checklist
|
7 months
|
Parent Teen Conflict
Time Frame: 7 months
|
Conflict Behavior Questionnaire, Video Interaction Tasks
|
7 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Satisfaction with Treatment
Time Frame: 7 months
|
Rating Scale of Patient Satisfaction with all aspects of Treatment
|
7 months
|
Quality of Therapeutic Relationship between the therapist and the patient
Time Frame: 7 months
|
Patient report on therapeutic alliance
|
7 months
|
Organization Skills
Time Frame: 7 months
|
Direct observation of recording homework and book bag organization
|
7 months
|
Executive Functioning
Time Frame: 7 months
|
BRIEF rating scale, DKEFS, AWMA
|
7 months
|
Motivation
Time Frame: 7 months
|
Motivation (readiness) ruler, hungry donkey task, choice delay task,
|
7 months
|
Parent academic Involvement
Time Frame: 7 months
|
Parent report of academic management, number of hours spent helping, video interaction task
|
7 months
|
parent-teen communication
Time Frame: 7 months
|
video tasks
|
7 months
|
parent readiness to change
Time Frame: 7 months
|
Motivation (readiness) ruler, parent change talk
|
7 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Sibley MH, Ortiz M, Rios-Davis A, Zulauf-McCurdy CA, Graziano PA, Bickman L. Stakeholder-Generated Implementation Strategies to Promote Evidence-Based ADHD Treatment in Community Mental Health. Adm Policy Ment Health. 2022 Jan;49(1):44-58. doi: 10.1007/s10488-021-01143-5. Epub 2021 May 14.
- Sibley MH, Graziano PA, Coxe S, Bickman L, Martin P. Effectiveness of Motivational Interviewing-Enhanced Behavior Therapy for Adolescents With Attention-Deficit/Hyperactivity Disorder: A Randomized Community-Based Trial. J Am Acad Child Adolesc Psychiatry. 2021 Jun;60(6):745-756. doi: 10.1016/j.jaac.2020.07.907. Epub 2020 Aug 28.
- Sibley MH, Graziano PA, Bickman L, Coxe SJ, Martin P, Rodriguez LM, Fallah N, Ortiz M. Implementing Parent-Teen Motivational Interviewing + Behavior Therapy for ADHD in Community Mental Health. Prev Sci. 2021 Aug;22(6):701-711. doi: 10.1007/s11121-020-01105-7.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 1, 2015
Primary Completion (Actual)
December 1, 2018
Study Completion (Actual)
October 31, 2020
Study Registration Dates
First Submitted
July 24, 2015
First Submitted That Met QC Criteria
February 24, 2016
First Posted (Estimate)
March 1, 2016
Study Record Updates
Last Update Posted (Actual)
February 3, 2021
Last Update Submitted That Met QC Criteria
February 2, 2021
Last Verified
February 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- R01MH106587 (U.S. NIH Grant/Contract)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Attention Deficit Hyperactivity Disorder
-
Cingulate TherapeuticsRecruitingPhase 3 Efficacy and Safety Laboratory Classroom Study in Pediatrics (6-12) With ADHD Using CTx-1301ADHD | Attention Deficit Hyperactivity Disorder | Attention Deficit Disorder With Hyperactivity | ADHD - Combined Type | Attention Deficit Hyperactivity Disorder Combined | Attention Deficit Hyper Activity | Attention-deficit HyperactivityUnited States
-
Ornit CohenUnknownAttention Deficit Hyperactivity Disorder | Attention Deficit Disorder With Hyperactivity | Attention Deficit Disorder | Attention Deficit Disorders With Hyperactivity | Attention Deficit Hyperactivity DisordersIsrael
-
Cingulate TherapeuticsPremier Research Group plcActive, not recruitingADHD | Attention Deficit Hyperactivity Disorder | ADHD - Combined Type | Attention Deficit Hyperactivity Disorder Combined | Attention Deficit Hyper Activity | Attention-deficit HyperactivityUnited States
-
Children's National Research InstituteRecruitingADHD | Attention Deficit Hyperactivity Disorder | Attention-Deficit Hyperactivity Disorder | Attention Deficit Disorder | ADD | ADHD Predominantly Inattentive Type | ADHD - Combined Type | ADHD, Predominantly Hyperactive - Impulsive | Attention-Deficit Disorder in Adolescence | Attention-Deficit Hyperactivity...United States
-
Fondation LenvalCompletedAttention Deficit Disorder With Hyperactivity | Attention Deficit Disorder Without HyperactivityFrance
-
University Hospital Bispebjerg and FrederiksbergMental Health Services in the Capital Region, DenmarkRecruitingSleep Disturbance | Neurodevelopmental Disorders | Attention Deficit Hyperactivity Disorder | Attention Deficit Disorder | Attention-Deficit Hyperactivity Disorder, Unspecified Type | Attention-deficit Hyperactivity | Hyperkinetic Conduct DisorderDenmark
-
Corium, Inc.Worldwide Clinical Trials; Premier Research Group plc; Almac; Prometrika, LLCRecruitingAttention Deficit/Hyperactivity DisorderUnited States
-
Corium, Inc.Premier Research Group plc; Almac; Prometrika, LLCActive, not recruitingAttention Deficit/Hyperactivity DisorderUnited States
-
Massachusetts General HospitalShire Human Genetic Therapies, Inc.Active, not recruitingAttention Deficit/Hyperactivity DisorderUnited States
-
Ataturk UniversityCompletedAttention-deficit/Hyperactivity DisorderTurkey
Clinical Trials on STAND (Behavior Therapy + Motivational Interviewing)
-
Florida International UniversityCompletedBehavior Therapy + MI Intervention (Supporting Teens' Academic Needs Daily) | Treatment as Usual
-
University Health Network, TorontoRyerson UniversityCompletedBulimia Nervosa | Eating DisorderCanada
-
University of Wisconsin, MadisonAgency for Healthcare Research and Quality (AHRQ)Completed
-
York UniversityRyerson University; University of Massachusetts, AmherstCompletedAnxiety Disorders | Generalized Anxiety DisorderCanada
-
Stanford UniversityRecruiting
-
VA Connecticut Healthcare SystemUnknown
-
University at AlbanyNational Institute of Mental Health (NIMH)Completed
-
Seinajoki Central HospitalTampere UniversityCompletedAnxiety Disorders | Major Depression | Dual Diagnosis | Substance Related DisordersFinland
-
National Yang Ming UniversityTaipei Veterans General Hospital, TaiwanCompletedMedication Adherence | Motivational Interviewing | Schizophrenia Spectrum DisorderTaiwan
-
University of WashingtonNational Institute on Minority Health and Health Disparities (NIMHD)CompletedDepression | Cardiovascular Diseases | Diabetes Mellitus, Type 2 | Dysthymic DisorderUnited States